{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:03:22Z","timestamp":1791644602234,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.pan.2026.03.003","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T02:49:54Z","timestamp":1772851794000},"page":"436-443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Re-evaluating routinely collected clinical and laboratory parameters in the preoperative risk assessment of intraductal papillary mucinous neoplasms: model development and internal validation"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6279-3689","authenticated-orcid":false,"given":"Camila","family":"Hidalgo Salinas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahip","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1735-3115","authenticated-orcid":false,"given":"Vishnu","family":"Jayaprakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D Brock","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0686-5544","authenticated-orcid":false,"given":"Brian J.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas A.","family":"Gonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5817-6146","authenticated-orcid":false,"given":"Christopher L.","family":"Wolfgang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1205-6477","authenticated-orcid":false,"given":"Greg D.","family":"Sacks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar A.","family":"Javed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pan.2026.03.003_bib1","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1001\/jamasurg.2021.1802","article-title":"Progression vs cyst stability of branch-duct intraductal papillary mucinous neoplasms after observation and surgery","volume":"156","author":"Marchegiani","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.pan.2026.03.003_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.37799","article-title":"Long-Term outcomes and risk of pancreatic cancer in intraductal papillary mucinous neoplasms","volume":"6","author":"de la Fuente","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.pan.2026.03.003_bib3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pan.2023.12.009","article-title":"International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas","volume":"24","author":"Ohtsuka","year":"2024","journal-title":"Pancreatology"},{"key":"10.1016\/j.pan.2026.03.003_bib4","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000006530","article-title":"Diagnostic performance of surgical indication for branch-duct or mixed-type intraductal papillary mucinous neoplasms of the Revised International Association of Pancreatology (IAP) 2023 Guidelines","author":"Jung","year":"2024","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.pan.2026.03.003_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/jhbp.12150","article-title":"Clinical and radiological predictive features for high-grade and invasive carcinoma in intraductal papillary mucinous neoplasms: a systematic review","volume":"33","author":"Hidalgo Salinas","year":"2026","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.pan.2026.03.003_bib6","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.hpb.2021.04.001","article-title":"The diagnostic and prognostic values of inflammatory markers in intraductal papillary mucinous neoplasm","volume":"23","author":"Kim","year":"2021","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.pan.2026.03.003_bib7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/SLA.0b013e318297ad6b","article-title":"Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis","volume":"258","author":"Mano","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.pan.2026.03.003_bib8","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/MPA.0000000000001342","article-title":"Neutrophil-to-Lymphocyte Ratio as a predictor of invasive carcinoma in patients with intraductal papillary mucinous neoplasms of the pancreas","volume":"48","author":"McIntyre","year":"2019","journal-title":"Pancreas"},{"key":"10.1016\/j.pan.2026.03.003_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.pan.2026.03.003_bib10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/SLA.0000000000001988","article-title":"Neutrophil-to-lymphocyte Ratio is a predictive marker for invasive malignancy in intraductal papillary mucinous neoplasms of the pancreas","volume":"266","author":"Gemenetzis","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.pan.2026.03.003_bib11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"key":"10.1016\/j.pan.2026.03.003_bib12","doi-asserted-by":"crossref","DOI":"10.5888\/pcd16.190013","article-title":"Small Area estimation of cancer risk factors and screening behaviors in US counties by combining two large national health surveys","volume":"16","author":"Liu","year":"2019","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/j.pan.2026.03.003_bib13","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/sim.7992","article-title":"Minimum sample size for developing a multivariable prediction model: PART II - binary and time-to-event outcomes","volume":"38","author":"Riley","year":"2019","journal-title":"Stat Med"},{"key":"10.1016\/j.pan.2026.03.003_bib14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"key":"10.1016\/j.pan.2026.03.003_bib15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0895-4356(03)00047-7","article-title":"Internal and external validation of predictive models: a simulation study of bias and precision in small samples","volume":"56","author":"Steyerberg","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.pan.2026.03.003_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h2622","article-title":"Statistics Notes: bootstrap resampling methods","volume":"350","author":"Bland","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.pan.2026.03.003_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve","volume":"143","author":"Hanley","year":"1982","journal-title":"Radiology"},{"key":"10.1016\/j.pan.2026.03.003_bib18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jclinepi.2019.09.016","article-title":"Validation of clinical prediction models: what does the \"calibration slope\" really measure?","volume":"118","author":"Stevens","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.pan.2026.03.003_bib19","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/(SICI)1097-0258(19970515)16:9<965::AID-SIM509>3.0.CO;2-O","article-title":"A comparison of goodness-of-fit tests for the logistic regression model","volume":"16","author":"Hosmer","year":"1997","journal-title":"Stat Med"},{"key":"10.1016\/j.pan.2026.03.003_bib20","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12916-019-1466-7","article-title":"Calibration: the Achilles heel of predictive analytics","volume":"17","author":"Van Calster","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.pan.2026.03.003_bib21","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/MPA.0b013e318215010c","article-title":"Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN","volume":"40","author":"Yamaguchi","year":"2011","journal-title":"Pancreas"},{"key":"10.1016\/j.pan.2026.03.003_bib22","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s11605-022-05428-4","article-title":"Predictors, patterns, and timing of recurrence provide Insight into the disease biology of invasive Carcinomas arising in Association with intraductal papillary mucinous neoplasms","volume":"26","author":"Habib","year":"2022","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.pan.2026.03.003_bib23","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/j.cgh.2024.05.043","article-title":"The revised Kyoto criteria and risk of malignancy among patients with intraductal papillary mucinous neoplasms","volume":"22","author":"Hamada","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.pan.2026.03.003_bib24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000540181","article-title":"Lymphocyte-to-Monocyte Ratio predicts survival for intraductal papillary mucinous neoplasm with associated invasive carcinoma of the pancreas: results from a high-volume Center","volume":"41","author":"Cui","year":"2024","journal-title":"Dig Surg"},{"key":"10.1016\/j.pan.2026.03.003_bib25","doi-asserted-by":"crossref","first-page":"32171","DOI":"10.18632\/oncotarget.16291","article-title":"Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis","volume":"8","author":"Bowen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.pan.2026.03.003_bib26","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00345-012-0942-x","article-title":"Clinical significance of preoperative peripheral blood neutrophil count in patients with non-metastatic upper urinary tract carcinoma","volume":"31","author":"Hashimoto","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.pan.2026.03.003_bib27","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.pan.2012.06.002","article-title":"The burning question: why is smoking a risk factor for pancreatic cancer?","volume":"12","author":"Pandol","year":"2012","journal-title":"Pancreatology"},{"key":"10.1016\/j.pan.2026.03.003_bib28","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/MPA.0000000000001550","article-title":"The diverse involvement of cigarette smoking in pancreatic cancer development and prognosis","volume":"49","author":"Weissman","year":"2020","journal-title":"Pancreas"},{"key":"10.1016\/j.pan.2026.03.003_bib29","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3389\/fphys.2013.00246","article-title":"Overview on how oncogenic Kras promotes pancreatic carcinogenesis by inducing low intracellular ROS levels","volume":"4","author":"Kong","year":"2013","journal-title":"Front Physiol"},{"key":"10.1016\/j.pan.2026.03.003_bib30","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.biopha.2018.07.157","article-title":"Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: an update on glucose toxicity","volume":"107","author":"Giri","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.pan.2026.03.003_bib31","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41419-022-05259-w","article-title":"Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma","volume":"13","author":"Liu","year":"2022","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.pan.2026.03.003_bib32","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S2468-1253(24)00346-7","article-title":"Launch of the PANC-PALS consortium","volume":"9","author":"Javed","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390326001237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390326001237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T20:49:40Z","timestamp":1777754980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390326001237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1424390326001237"],"URL":"https:\/\/doi.org\/10.1016\/j.pan.2026.03.003","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Re-evaluating routinely collected clinical and laboratory parameters in the preoperative risk assessment of intraductal papillary mucinous neoplasms: model development and internal validation","name":"articletitle","label":"Article Title"},{"value":"Pancreatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pan.2026.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V. on behalf of IAP and EPC.","name":"copyright","label":"Copyright"}]}}